Skip to content

*Prospective cohort study on the prevalence of obstructive sleep apnea in patients with head and neck cancer treated with either radiotherapy, chemoradiation or surgery*

*Prospective cohort study on the prevalence of obstructive sleep apnea in patients with head and neck cancer treated with either radiotherapy, chemoradiation or surgery* - prevalence of OSAS before and after treatment of head and neck cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33028
Enrollment
100
Registered
2010-03-12
Start date
2009-09-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea syndrome sleep disordered breathing

Interventions

None listed

Sponsors

Antoni van Leeuwenhoek Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: T2-4 laryngeal carcinoma, treated with radiotherapy T3-4 oral and oropharyngeal carcinoma treated with a commandoprocedure (with/without postoperative (chemo)radiation.) T2-4 oro- or hypopharyngeal cancer treated with chemoradiation

Exclusion criteria

Exclusion criteria: Age older than 18 or younger than 80 Stridor and need for tracheostomy before/during treatment Inability to undergo polysomnography Inability to complete questionnaires Other conditions deemed by the Principle Investigator that make the subject ineligible for protocol procedures

Design outcomes

Primary

MeasureTime frame
Incidence of OSAS in 3 populations with Head and neck cancer

Secondary

MeasureTime frame
Influence of treatment on the OSAS

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)